You are here: Industry Insights > Shire

News List

Takeda receives shareholders’ approval to acquire Shire pharmaceutical-technology
December 06, 2018
Takeda Pharmaceutical has secured shareholder approval for the issuance of its shares necessary to implement the proposed $62bn acquisition of Shire....
Takeda could rack up $10B in selloffs after controversial Shire buyout: report fiercepharma
December 04, 2018
With a crucial shareholder vote looming, Takeda is on an aggressive push to win investor support for a Shire buyout expected to load the company with debt. Now, a top executive says that debt burden could be $10 billion lighter after the deal closes.
Shire's Takhzyro scores EU approval in rare genetic disorder hereditary angioedema pharmafile
December 04, 2018
Shire has announced that it has secured European approval for its subcutaneous injection Takhzyro (lanadelumab) for the routine prevention of attacks as a result of hereditary angioedema (HAE)...
Shire receives EU approval for Takhzyro pharmatimes
December 03, 2018
Takhzyro (lanadelumab) is a subcutaneous injection indicated for routine prevention of recurrent HAE attacks in patients aged 12 years and older.
Shire’s Veyvondi approved in Europe for bleeding disorder pharmatimes
November 26, 2018
The green light allows doctors to prescribe the therapy for the treatment of bleeding events and treatment/prevention of surgical bleeding in adults with the condition, when desmopressin treatment alone is ineffective or not indicated.
With EU blessing, Takeda clears final regulatory hurdle for Shire buyout—on one condition fiercepharma
November 26, 2018
Following major regulators in the U.S., China and Japan, the European Commission has given Takeda the go-ahead for its $62 billion acquisition of Shire—on one condition that Takeda is willing to fulfill.
Takeda gets European blessing for Shire acquisition pharmatimes
November 22, 2018
The European Commission has given its blessing for the proposed £46-billion acquisition of Shire by Takeda, paving the way for the deal’s completion.
With EU blessing, Takeda clears final regulatory hurdle for Shire buyout—on one condition fiercepharma
November 22, 2018
Following major regulators in the U.S., China and Japan, the European Commission has given Takeda the go-ahead for its $62 billion acquisition of Shire—on one condition that Takeda is willing to fulfill.
Takeda sets target date to close $62B Shire deal biospectrumasia
November 19, 2018
The deal would be the largest-ever overseas acquisition by a Japanese company.Singapore Aiming to close its deal for Sh
Takeda sets target date to close $62B Shire deal biospectrum
November 14, 2018
The deal would be the largest-ever overseas acquisition by a Japanese company.

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page